Avci; Oktay

Patent Applications and Registrations

Patent applications and USPTO patent grants for Avci; Oktay.The latest application filed is for "drug treatment of psoriasis and of other skin disorders associated with inhibition of differentiation of epidermal cells".

Company Profile

0.6.10

Avci; Oktay - Izmir TR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Drug Treatment Of Psoriasis And Of Other Skin Disorders Associated With Inhibition Of Differentiation Of Epidermal Cells App 20180185391 - Tas; Sinan ; et al.	2018-07-05
Drug treatment of tumors wherein hedgehog/smoothened signaling is utilized for inhibition of apoptosis of tumor cells App 20170326118 - Tas; Sinan ; et al.	2017-11-16
Treatment of psoriasis and of other skin disorders associated with inhibition of differentiation of epidermal cells Grant 9,757,361 - Tas , et al. September 12, 2	2017-09-12
Use of a specific inhibitor of hedgehog/smoothened signaling on hyperpigmented skin to obtain decrease of pigmentation Grant 8,025,893 - Tas , et al. September 27, 2	2011-09-27
Medicament for treatment of tumors wherein hedgehog/smoothened signaling is employed for inhibition of apoptosis of the tumor cells App 20110104254 - Tas; Sinan ; et al.	2011-05-05
Use of cyclopamine in the treatment of basal cell carcinoma and other tumors Grant 7,893,078 - Tas , et al. February 22, 2	2011-02-22
Use Of Cyclopamine In The Treatment Of Basal Cell Carcinoma And Other Tumors App 20100048725 - Tas; Sinan ; et al.	2010-02-25
Pharmaceutical composition comprising a corticosteroid and a specific inhibitor of hedgehog/smoothened signaling Grant 7,629,352 - Tas , et al. December 8, 2	2009-12-08
Treatment of psoriasis and of other skin disorders associated with inhibition of differentiation of epidermal cells App 20090286822 - Tas; Sinan ; et al.	2009-11-19
Use of cyclopamine in the treatment of psoriasis Grant 7,605,167 - Tas , et al. October 20, 2	2009-10-20
Use Of A Specific Inhibitor Of Hedgehog/smoothened Signaling On Hyperpigmented Skin To Obtain Decrease Of Pigmentation App 20080089915 - Tas; Sinan ; et al.	2008-04-17
Pharmaceutical Composition Comprising A Corticosteroid And A Specific Inhibitor Of Hedgehog/smoothened Signaling App 20080090790 - Tas; Sinan ; et al.	2008-04-17
Use of cyclopamine in the treatment of psoriasis App 20040072913 - Tas, Sinan ; et al.	2004-04-15
Use of cyclopamine in the treatment of basal cell carcinoma and other tumors App 20040072914 - Tas, Sinan ; et al.	2004-04-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.